Your session is about to expire
← Back to Search
SHE-WOMEN Program for Cervical Cancer Prevention (SHE-WOMEN Trial)
N/A
Waitlist Available
Led By Megha Ramaswamy, PhD, MPH
Research Sponsored by University of Kansas Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months post behavioral intervention, 24 months post behavioral intervention, 36 months post behavioral intervention
Awards & highlights
SHE-WOMEN Trial Summary
This trial will test an expansion of an existing cervical cancer prevention intervention to a broader population to see if it is effective and sustainable.
Who is the study for?
This trial is for women who are scheduled to leave jail within the next three days and are interested in improving their knowledge about sexual health, including cervical and breast cancer prevention, birth control, and preventing sexually transmitted infections. Women showing severe psychological distress or those actively intoxicated cannot participate.Check my eligibility
What is being tested?
The SHE-WOMEN intervention is being tested to see if it can help reduce health disparities by educating vulnerable populations of women on various aspects of sexual health. The study aims to create a sustainable model for disseminating this information effectively.See study design
What are the potential side effects?
Since the intervention involves education and empowerment rather than medical treatment, there are no direct side effects associated with medications or procedures. However, participants may experience emotional responses to the material.
SHE-WOMEN Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months post behavioral intervention, 24 months post behavioral intervention, 36 months post behavioral intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months post behavioral intervention, 24 months post behavioral intervention, 36 months post behavioral intervention
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Beliefs related to Breast Cancer
Body Weight Changes
Change in HPV Vaccination receipt
+16 moreSHE-WOMEN Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Deliver text-Web intervention to (N ~100) women
Researchers will deliver the integrated, multimedia electronic women's health literacy intervention arm of SHEWomen in text-Web format for individuals recently released from jail. Two health educators will be responsible for delivering content to participants, with an estimated contact time of ~10 hours pushed to participants over approximately a 5-day period.
Group II: ControlActive Control1 Intervention
15 minute discharge planning session with health educator
Health education booklet containing SHE-Women intervention content in print form(N~100)
access to health educator via text message
Find a Location
Who is running the clinical trial?
University of Kansas Medical CenterLead Sponsor
458 Previous Clinical Trials
168,809 Total Patients Enrolled
Megha Ramaswamy, PhD, MPHPrincipal Investigator - University of Kansas School of Medicine
University of Kansas Medical Center
1 Previous Clinical Trials
261 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are not experiencing serious mental or emotional distress.You cannot currently be under the influence of drugs or alcohol.
Research Study Groups:
This trial has the following groups:- Group 1: Control
- Group 2: Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many participants are currently eligible for this research trial?
"Affirmative, clinicaltrials.gov reveals that recruitment has opened for this research project which was initially posted on the 11th of November 2019 and recently modified on the 2nd of February 2021. 200 applicants are sought from a single site."
Answered by AI
Are there still opportunities to join this medical experiment?
"Affirmative. Data hosted on clinicaltrials.gov shows that this research is actively enrolling participants, with the study first advertised on November 11th 2019 and last edited today February 11th 2021. The trial seeks 200 patients from a single medical centre."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger